DNDi Taps Pfizer Compound Library | November 30, 2009 Issue - Vol. 87 Issue 48 | Chemical & Engineering News
Volume 87 Issue 48 | p. 19 | Concentrates
Issue Date: November 30, 2009

DNDi Taps Pfizer Compound Library

Department: Business
Keywords: DNDI, Pfizer, neglected diseases

Pfizer and the Drugs for Neglected Diseases initiative are joining to advance the development of cures for human African trypanosomiasis, visceral leishmaniasis, and Chagas disease, which afflict people in the developing world. Under the agreement, scientists in institutions affiliated with DNDi will test at least 150,000 compounds in Pfizer’s library of novel chemical entities against the parasites that cause the three diseases. According to DNDi, Pfizer’s compound library has never been explored for treatments for these diseases.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment